IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial
 




EMBO Molecular Medicine - Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and other Important Metrics


Impact Factor

10.28

H-Index

90

Rank

287

SJR

5.033

Note: The impact factor shown here is equivalent to citescore and is, therefore, used as a replacement for the same. Citescore is produced by Scopus, and can be a little higher or different compared to the impact factor produced by Journal Citation Report. Please refer to Web of Science data source for checking the exact journal impact factor ™ (Thomson Reuters) metric.

Title EMBO Molecular Medicine
Publication Type journal
Subject Area, Categories, Scope Molecular Medicine (Q1)
h-index 90
Overall Rank/Ranking 287
SCImago Journal Rank (SJR) 5.033
Impact Factor 10.28
Publisher John Wiley & Sons Ltd.
Country United Kingdom
ISSN 17574676, 17574684



About EMBO Molecular Medicine


EMBO Molecular Medicine is a journal covering the technologies/fields/categories related to Molecular Medicine (Q1). It is published by John Wiley & Sons Ltd.. The overall rank of EMBO Molecular Medicine is 287. According to SCImago Journal Rank (SJR), this journal is ranked 5.033. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 90. The best quartile for this journal is Q1.

The ISSN of EMBO Molecular Medicine journal is 17574676, 17574684. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. EMBO Molecular Medicine is cited by a total of 3190 articles during the last 3 years (Preceding 2018).

EMBO Molecular Medicine Impact Factor 2018-2019


The impact factor (IF) 2018 of EMBO Molecular Medicine is 10.28, which is computed in 2019 as per it's definition. EMBO Molecular Medicine IF is increased by a factor of 0.47 and approximate percentage change is 4.79% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.



Table Setting

EMBO Molecular Medicine Impact Factor 2019 Prediction


IF 2018 of EMBO Molecular Medicine is 10.28. If the same upward trend persists, impact factor of joule may rise in 2019 as well.

EMBO Molecular Medicine h-index


  Table Setting

EMBO Molecular Medicine has an h-index of 90. It means 90 articles of this journal have more than 90 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

EMBO Molecular Medicine ISSN


The ISSN of EMBO Molecular Medicine is 17574676, 17574684. ISSN stands for International Standard Serial Number. An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

EMBO Molecular Medicine Rank and SCImago Journal Rank (SJR)


The overall rank of EMBO Molecular Medicine is 287. According to SCImago Journal Rank (SJR), this journal is ranked 5.033. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

EMBO Molecular Medicine Publisher


Table Setting

EMBO Molecular Medicine is published by John Wiley & Sons Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2009-ongoing. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

How to publish in EMBO Molecular Medicine


If your research field is/are related to Molecular Medicine (Q1), then you can visit the official website of the journal.

Acceptance Rate


To check the acceptance rate of this journal, visit here.

Call for Paper, Submission Guidelines, Notification Date, and Submission Deadline 2020/2019


Visit the official website of the journal/conference for the call for paper, submission guidelines, notification date, and submission deadlines.


Source: https://www.scimagojr.com/journalrank.php



Impact Factor, h-Index, and other important details of other Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Factor
Design and Culture journal 17410 Taylor & Francis 7 0.48
The gulf journal of oncology journal 22391 Gulf Federation for Cancer Control 8 0.36
Lymphologie in Forschung und Praxis journal 26958 Kagerer Kommunikation 8 0.20
Cancer Metastasis - Biology and Treatment book series 19614 Springer Verlag 5 0.00
Journal of Agricultural and Environmental Ethics journal 10383 Kluwer Academic Publishers 41 1.60
Artificial Intelligence for Engineering Design, Analysis and Manufacturing: AIEDAM journal 12420 Cambridge University Press 49 1.34
Tribology Transactions journal 6953 Taylor & Francis 59 1.55
Studii si cercetari lingvistice journal 31647 Editura Academiei Romane 1 0.04
R and D Management journal 3479 Blackwell Publishing Inc. 91 2.92
Ratio juris journal 21869 Basil Blackwell 8 0.31

Check complete list

Year wise Impact Factor (IF) of EMBO Molecular Medicine

Year Impact Factor (IF)
2019Coming Soon
201810.28
20179.81
20168.64
20159.48
20149.29



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central | United Kingdom

Trends in Molecular Medicine
Elsevier BV | Netherlands

Journal for ImmunoTherapy of Cancer
BioMed Central | United Kingdom

Molecular Therapy
Cell Press | United States

Molecular Cancer
BioMed Central | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag | Switzerland